Citation 14575

IKEDA,K: KATO,A: ADACHI,I: HARAGUCHI,M: ASANO,N:. (2003). ALKALOIDS FROM THE POISONOUS PLANT IPOMOEA CARNEA: EFFECTS ON INTRACELLULAR LYSOSOMAL GLYCOSIDASE ACTIVITIES IN HUMAN LYMPHOBLAST CULTURES.. 57(26)

Citation Details

Title	ALKALOIDS FROM THE POISONOUS PLANT IPOMOEA CARNEA: EFFECTS ON INTRACELLULAR LYSOSOMAL GLYCOSIDASE ACTIVITIES IN HUMAN LYMPHOBLAST CULTURES.
Authors	IKEDA,K: KATO,A: ADACHI,I: HARAGUCHI,M: ASANO,N:
Year	2003
Volume	57
Issue	26

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Ipomoea carnea (CONVOLVULACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	SWAINSONINEPROLINE,L: N-METHYL-TRANS-4-HYDROXY:	None
2	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SWAINSONINE	INACTIVE
3	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SWAINSONINE	INACTIVE
4	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SWAINSONINE	INACTIVE
5	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	SWAINSONINE	INACTIVE
6	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SWAINSONINE	INACTIVE
7	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SWAINSONINE	INACTIVE
8	ALPHA-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SWAINSONINE	INACTIVE
9	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LENTIGINOSINE,2-EPI:	INACTIVE
10	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LENTIGINOSINE,2-EPI:	INACTIVE
11	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	LENTIGINOSINE,2-EPI:	INACTIVE
12	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LENTIGINOSINE,2-EPI:	INACTIVE
13	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LENTIGINOSINE,2-EPI:	ACTIVE
14	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LENTIGINOSINE,2-EPI:	INACTIVE
15	ALPHA-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LENTIGINOSINE,2-EPI:	INACTIVE
16	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-1	INACTIVE
17	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-1	ACTIVE
18	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-1	INACTIVE
19	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-1	INACTIVE
20	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-1	INACTIVE
21	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-1	INACTIVE
22	ALPHA-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-1	INACTIVE
23	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-2	INACTIVE
24	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-2	ACTIVE
25	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-2	ACTIVE
26	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-2	INACTIVE
27	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-2	INACTIVE
28	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-2	INACTIVE
29	ALPHA-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-2	INACTIVE
30	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-3	INACTIVE
31	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-3	ACTIVE
32	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-3	INACTIVE
33	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-3	INACTIVE
34	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-3	ACTIVE
35	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-3	INACTIVE
36	ALPHA-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE B-3	INACTIVE
37	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE C-1	INACTIVE
38	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE C-1	ACTIVE
39	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE C-1	INACTIVE
40	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE C-1	INACTIVE
41	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE C-1	INACTIVE
42	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE C-1	INACTIVE
43	ALPHA-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALYSTEGINE C-1	INACTIVE

Citation 14575

Citation Details

Summary

Organisms and Their Experiments (1)

Ipomoea carnea (CONVOLVULACEAE)

Show SPARQL Queries (1)

Query 1